PATENT CLAIM ANALYSIS

Application Number: 15894696
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "428000"]

Abstract:
Prostamide-containing biodegradable intraocular implants, prostamide compounds, prostamide-containing pharmaceutical compositions, and methods for making and using such implants and compositions for the immediate and sustained reduction of intraocular pressure and treatment of glaucoma in an eye of a patient are described.

Claim (Index 5):
A biodegradable intraocular implant according to  claim 4 , wherein the implant is effective for reducing IOP in a mammalian eye by 20-30% for 5 months or more relative to the IOP in the eye before receiving the implant.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 88.0
- Lexical Diversity: 1.375
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14211265', '15075922', '14529526', '15350471', '14213294']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8218865376647004
- 35 USC 102 Novelty (BERT): 0.5782563734045797
- Combined Prediction Score: 0.7975235212386884
- Mean Citation Score: 483.80722
- Max Citation Score: 568.7078
- Similarity Product: 370.6098340350509

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test